Komipharm International Co., Ltd. (KOSDAQ:041960)
South Korea flag South Korea · Delayed Price · Currency is KRW
9,270.00
-470.00 (-4.83%)
Aug 21, 2026, 3:30 PM KST

Komipharm International Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
21,36127,88812,44814,82010,80511,992
Short-Term Investments
5,952-00-0-23.08
Trading Asset Securities
--10,000--1,914
Cash & Short-Term Investments
27,31327,88822,44814,82010,80513,929
Cash Growth
43.61%24.23%51.47%37.16%-22.43%-18.57%
Accounts Receivable
19,94917,32315,69612,04210,8499,858
Other Receivables
5.198.921.3447.6725.07150.49
Receivables
25,02122,96921,80817,90113,98412,848
Inventory
16,22115,18414,56614,90116,25414,176
Prepaid Expenses
572.65392.44181.041,723327.35183.49
Other Current Assets
2,6942,054932.06667.43221.76315.9
Total Current Assets
71,82268,48759,93550,01241,59341,452
Property, Plant & Equipment
56,87455,82455,78464,23966,52270,141
Long-Term Investments
651.77631.541,0102,6191,2232,220
Other Intangible Assets
1,6031,6881,84142.4654.7662.17
Long-Term Accounts Receivable
-----0
Long-Term Deferred Charges
5,1943,9002,0521,172753.46847.1
Other Long-Term Assets
2,9293,3322,128470.071,579539.54
Total Assets
139,118133,915122,767118,598111,751115,262

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
5,9064,8645,3852,6153,7462,756
Accrued Expenses
475.34362.53309.88437.59274.77329.23
Short-Term Debt
27,51327,79733,71936,73121,50019,500
Current Portion of Long-Term Debt
5,5455,545829.463,53113,141731.05
Current Portion of Leases
229.15203.67185.04245.64174.68154.46
Other Current Liabilities
15,30413,9805,8058,6682,2112,213
Total Current Liabilities
54,97352,75246,23352,22841,04725,685
Long-Term Debt
7,6946,8108,8964,3263,05712,798
Long-Term Leases
312.66315.96209.6267.91258.85237.84
Long-Term Deferred Tax Liabilities
1,8541,8541,7611,7611,7411,741
Other Long-Term Liabilities
125.93125.93129.27002,394
Total Liabilities
64,95961,85857,22958,58346,10442,856

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
7,3897,3767,0627,0606,4196,419
Additional Paid-In Capital
88,78485,83569,11573,87480,27978,807
Retained Earnings
-16,403-17,879-10,670-23,783-24,804-18,290
Treasury Stock
-9,742-8,609-5,730-2,052-1,989-989.46
Comprehensive Income & Other
1,6592,8162,5041,238725.91513.98
Total Common Equity
71,68669,53962,28056,33860,63166,460
Minority Interest
2,4732,5193,2573,6775,0165,946
Shareholders' Equity
74,15972,05765,53860,01565,64772,406
Total Liabilities & Equity
139,118133,915122,767118,598111,751115,262

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
41,29440,67243,83945,10238,13133,422
Net Cash (Debt)
-13,981-12,785-21,391-30,282-27,327-19,493
Net Cash Growth
------
Net Cash Per Share
-197.29-180.73-306.68-431.66-388.82-277.38
Filing Date Shares Outstanding
68.7271.9169.2870.1570.1270.28
Total Common Shares Outstanding
68.7271.9169.2870.1570.1270.28
Working Capital
16,84915,73413,702-2,217545.1115,768
Book Value Per Share
1043.22967.05898.99803.07864.66945.70
Tangible Book Value
70,08467,85060,43956,29560,57666,398
Tangible Book Value Per Share
1019.90943.57872.41802.46863.88944.81
Land
14,14914,14914,14917,99817,90318,678
Buildings
42,22842,22842,17744,44444,33744,359
Machinery
30,27727,54026,41025,51425,14624,625
Construction In Progress
10,22410,9529,89410,80410,71910,719